Age in Years at Admission
|
75–84 vs. 65–74 |
1.35 |
1.23 |
1.49 |
<0.0001 |
85–89 vs. 65–74 |
2.07 |
1.86 |
2.30 |
<0.0001 |
90+ vs. 65–74 |
2.49 |
2.24 |
2.78 |
<0.0001 |
Sex: Male vs. Female |
0.95 |
0.89 |
1.02 |
0.17 |
Patient Location: NCHS Urban–Rural Code
|
Central counties of metro areas of ≥1 million population (Ref) |
- |
- |
- |
- |
Fringe counties of metro areas of ≥1 million population |
0.98 |
0.88 |
1.09 |
0.69 |
Counties in metro areas of 250,000–999,999 population |
1.13 |
1.02 |
1.25 |
0.02 |
Counties in metro areas of 50,000–249,999 population |
1.39 |
1.23 |
1.58 |
<0.0001 |
Micropolitan counties |
1.05 |
0.88 |
1.24 |
0.62 |
Not metropolitan or micropolitan counties |
1.44 |
1.22 |
1.68 |
<0.0001 |
Median Household Income National Quartile for Patient’s ZIP Code
|
0–25th percentile (Ref) |
- |
- |
- |
- |
26th to 50th percentile (median) |
0.96 |
0.88 |
1.06 |
0.45 |
51st to 75th percentile |
1.02 |
0.92 |
1.13 |
0.69 |
76th to 100th percentile |
1.09 |
0.98 |
1.21 |
0.13 |
Primary Expected Payer
|
Medicaid vs. Medicare |
1.08 |
0.76 |
1.52 |
0.67 |
Private insurance vs. Medicare |
1.51 |
1.32 |
1.74 |
<0.0001 |
Self-pay vs. Medicare |
1.29 |
0.81 |
2.05 |
0.29 |
No charge vs. Medicare |
0.00 |
0.00 |
N/A |
1.00 |
Others vs. Medicare |
3.12 |
2.60 |
3.76 |
<0.0001 |
Admission Day: Admitted Weekday vs. Weekend |
1.03 |
0.96 |
1.12 |
0.39 |
Admission Type: Non-elective vs. Elective admission |
1.11 |
0.90 |
1.36 |
0.33 |
All Patient Refined DRG: Severity of Illness Subclass
|
Minor loss of function (Ref) |
- |
- |
- |
- |
Moderate loss of function |
2.02 |
1.49 |
2.73 |
<0.0001 |
Major loss of function |
9.57 |
7.14 |
12.84 |
<0.0001 |
Extreme loss of function |
48.57 |
36.15 |
65.26 |
<0.0001 |
Comorbidities
|
AIDS |
0.00 |
0.00 |
N/A |
1.00 |
Alcohol abuse |
1.24 |
0.99 |
1.55 |
0.06 |
Deficiency anemias |
0.87 |
0.80 |
0.95 |
0.00 |
Rheumatoid arthritis/collagen vascular diseases |
1.07 |
0.89 |
1.29 |
0.45 |
Chronic blood loss anemia |
0.73 |
0.49 |
1.10 |
0.14 |
Congestive heart failure |
1.20 |
1.10 |
1.31 |
<0.0001 |
Chronic pulmonary disease |
0.93 |
0.86 |
1.01 |
0.08 |
Coagulopathy |
1.18 |
1.05 |
1.32 |
0.01 |
Depression |
0.83 |
0.73 |
0.94 |
0.00 |
Drug abuse |
0.57 |
0.33 |
0.96 |
0.04 |
Hypertension (combine uncomplicated and complicated) |
0.88 |
0.81 |
0.95 |
0.00 |
Hypothyroidism |
0.89 |
0.81 |
0.98 |
0.02 |
Liver disease |
1.21 |
0.94 |
1.56 |
0.14 |
Lymphoma |
0.77 |
0.58 |
1.02 |
0.07 |
Fluid and electrolyte disorders |
1.11 |
1.03 |
1.19 |
0.00 |
Other neurological disorders |
1.16 |
1.04 |
1.30 |
0.01 |
Obesity |
0.77 |
0.66 |
0.91 |
0.00 |
Paralysis |
1.21 |
1.04 |
1.41 |
0.01 |
Peripheral vascular disorders |
0.97 |
0.87 |
1.09 |
0.65 |
Psychoses |
1.26 |
1.01 |
1.58 |
0.04 |
Pulmonary circulation disorders |
0.94 |
0.82 |
1.08 |
0.41 |
Renal failure |
0.96 |
0.88 |
1.05 |
0.34 |
Solid tumor without metastasis |
1.58 |
1.35 |
1.85 |
<0.0001 |
Metastatic cancer |
2.30 |
2.00 |
2.64 |
<0.0001 |
Valvular disease |
0.77 |
0.69 |
0.86 |
<0.0001 |
Weight loss |
0.74 |
0.68 |
0.80 |
<0.0001 |
Number of Chronic Conditions
|
1–4 (Ref) |
- |
- |
- |
- |
5–6 |
0.90 |
0.81 |
1.00 |
0.06 |
7–8 |
0.84 |
0.75 |
0.95 |
0.00 |
>8 |
0.80 |
0.70 |
0.92 |
0.00 |
Hospital Characteristics
|
Bed size of hospital: Medium vs. Small |
1.06 |
0.94 |
1.18 |
0.35 |
Large vs. Small |
1.00 |
0.90 |
1.11 |
0.99 |
Hospital urban–rural designation
|
Large metropolitan areas with at least 1 million residents (Ref) |
- |
- |
- |
- |
Small metropolitan areas with less than 1 million residents |
1.32 |
1.10 |
1.58 |
0.0025 |
Micropolitan areas |
0.67 |
0.51 |
0.88 |
0.0044 |
Not metropolitan or micropolitan (non-urban residual) |
1.00 |
1.00 |
1.00 |
N/A |
Teaching status of urban hospitals:
|
Metropolitan teaching vs. metropolitan non-teaching |
0.91 |
0.84 |
0.99 |
0.02 |
Control/ownership of hospital:
|
Private, not-profit vs. government, nonfederal |
1.01 |
0.92 |
1.12 |
0.80 |
Private, invest-own vs. government, nonfederal |
1.14 |
1.00 |
1.30 |
0.04 |